Suggestions
Glenn Harnett MD
Chief Executive Officer at No Resistance
Glenn Harnett, MD, is the Chief Executive Officer of No Resistance Consulting Group, a Clinical Trial Site Management Organization based in Birmingham, Alabama. He has been in this role since March 2016, leading the organization in conducting clinical trials efficiently and in compliance with Good Clinical Practice (GCP) standards. Under his leadership, No Resistance has developed a network of high-volume medical practices to facilitate clinical research.12
Educational Background
Dr. Harnett earned his medical degree from the Medical College of Georgia at Augusta University (1997-2001) and completed his residency in Emergency Medicine at Emory University (2001-2004), where he served as Chief Resident. He also holds a Bachelor's degree in Psychology from the University of New Hampshire (1985-1990).1
Professional Experience
Before founding No Resistance Consulting Group, Dr. Harnett held several significant positions:
- Chief Medical Officer and VP of Business Development at Blockit (2018-2019), where he worked on integrating healthcare systems for improved patient referrals.
- Chief Medical Officer at American Family Care (2011-2016), contributing to the organization's expansion from 17 to 185 clinics.
- Emergency Medicine Physician at Georgia Emergency Associates (2004-2011), where he held various leadership roles.123
Contributions and Recognition
Dr. Harnett is recognized for his contributions to urgent care medicine and antibiotic stewardship. He received the inaugural Urgent Care Association Antibiotic Stewardship Champion Award for his initiatives to combat inappropriate antibiotic use within the industry.3 His expertise extends to clinical trial design and management, making him a respected figure in clinical research and healthcare management.4
Overall, Dr. Harnett's extensive background in emergency medicine and clinical research positions him as a key leader in advancing healthcare practices through effective clinical trial management.


